Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals

Development of small amphiphilic Rhenium and Tc-99m tricarbonyl complexes

Michael Adam, Eszter Boros, Urs Hafeli, Brian Patrick and Chris Orvig
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1893;
Michael Adam
1TRIUMF, Life Sciences, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eszter Boros
2University of British Columbia, Department of Chemistry, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Urs Hafeli
3University of British Columbia, Faculty of Pharmaceutical Sciences, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Patrick
2University of British Columbia, Department of Chemistry, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Orvig
2University of British Columbia, Department of Chemistry, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1893

Objectives Normal 0 Our aim was to develop a simple, small and non-specific “Technetium-based” complex with potential uptake in a large range of different tissues, by exploring the in-vivo properties of 3 novel, amphiphilic metal complexes of the [Tc(CO)3]+ core.

Methods Three small, amphiphilic, C8, Tc-99m chelates were synthesized from the highly stable fac-[99mTc(CO)3(H2O)3]+ reagent. Tumor bearing mice were injected with the complexes and images obtained out to 4 hours on an animal SPECT/CT scanner. Biodistributions were also carried out at the 4 hour time point.

Results Normal 0 Labeling with [99mTc(CO)3]+ showed fast complex formation and high stability. We showed distinct localization of our small amphiphilic molecules in in vivo systems depending on the charge of their polar moiety obtained through biodistribution (4h) and imaging (15 minutes, 1h, 2h and 4h) with female C57Bl/6 mice.

Conclusions Normal 0 The obtained results show that where as a change of neutral charge to zwitterionic seems to facilitate metabolism of the corresponding compound through the intestinal system, the corresponding anionic compound is excreted at an even higher rate exclusively through the renal tract.Unfortunately, none of the 3 investigated complexes showed significant brain, tumor or heart uptake. The lack of heart uptake confirms negatively charged or zwitterionic complexes not to show suitable ionicity compared to other, cationic complexes with high myocaridial uptake.

Research Support We wish to thank the Natural Sciences and Engineering Research Council of Canada for generous financial support.

  • © 2009 by Society of Nuclear Medicine
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Development of small amphiphilic Rhenium and Tc-99m tricarbonyl complexes
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Development of small amphiphilic Rhenium and Tc-99m tricarbonyl complexes
Michael Adam, Eszter Boros, Urs Hafeli, Brian Patrick, Chris Orvig
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1893;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Development of small amphiphilic Rhenium and Tc-99m tricarbonyl complexes
Michael Adam, Eszter Boros, Urs Hafeli, Brian Patrick, Chris Orvig
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1893;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals

  • Evaluation of single amino acid chelate (SAAC) derivatives for the regioselective radiolabeling of peptides with technetium-99m
  • Synthesis and in vivo stability of new class of Cu-64 complexes as potential bifunctional chelators
  • Development of angiogenesis therapy agent: 177Lu-NOTA-SCN-c(RGDyK)
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals

New Radiopharmaceuticals-Broader/General Applications Posters

  • Advancing radiopharmaceuticals through architectural innovation
  • A simple test for tetrabutylammonium in 18F-FLT
  • Prokineticin receptors antagonist PC-10 as a biomarker for imaging inflammatory pain
Show more New Radiopharmaceuticals-Broader/General Applications Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire